Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting
Authors:
- The Tigecycline GroupTGThe Tigecycline Group
- Philippe MontraversPMPhilippe Montravers
- Hervé DupontHDHervé Dupont
- Jean-Pierre BedosJBJean-Pierre Bedos
- Philippe BretPBPhilippe Bret
Open Access
- 29 May 2014
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 40 (7) , 988-997
Abstract
Purpose This prospective observational study aimed at describing prescription patterns of tigecycline and patient outcomes in 26 French intensive care units (ICU). Methods Data of consecutive cases of adult patients treated with tigecycline were collected from the initiation until 7 days after the end of treatment. Response to treatment was classified as success, failure or undetermined and analyses were presented according to severity (SOFA score P < 0.001). Success rate was 65 % for patients alive at the end of treatment. Success rates tended to decrease with illness severity, immunosuppression, bacteraemia and obesity. Survival rate at day 28 was 85 % in the whole cohort and significantly higher in the less severely ill patients (P < 0.001). Conclusions Tigecycline success rates appear comparable to those reported in clinical studies in ICU with severe infections. Tigecycline could be an alternative in ICU patients.Keywords
This publication has 42 references indexed in Scilit:
- Adding risk factors for potentially resistant pathogens, increasing antibiotic pressure and risk creating the “untreatable bacteria”: time to change directionIntensive Care Medicine, 2013
- Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority TrialsClinical Infectious Diseases, 2012
- Efficacy and safety of tigecycline: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2011
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious DiseaseAntimicrobial Agents and Chemotherapy, 2011
- Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trialBMC Infectious Diseases, 2010
- Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacinDiagnostic Microbiology and Infectious Disease, 2009
- Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumoniaDiagnostic Microbiology and Infectious Disease, 2008
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Users' Guides to the Medical LiteratureJAMA, 1994
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973